Di Nuzzo Private Wealth, Inc. Moderna, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $579 Million
- Q2 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 21 shares of MRNA stock, worth $1,326. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 16
31.25%
Holding current value
$1,326
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
1,114Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.74 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.5 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.61 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$949 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$456 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $24.7B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...